IBM WebSphere Portal 7.0.0.x/8.0.0.x Selfcare Portlet Trace File credentials management
| CVSS Meta Temp Score | Current Exploit Price (≈) | CTI Interest Score |
|---|---|---|
| 5.5 | $5k-$25k | 0.00 |
Summary
A vulnerability was found in IBM WebSphere Portal 7.0.0.x/8.0.0.x. It has been rated as problematic. This impacts an unknown function of the component Selfcare Portlet. Performing a manipulation as part of Trace File results in credentials management. This vulnerability is reported as CVE-2013-2951. The attack requires a local approach. No exploit exists.
Details
A vulnerability was found in IBM WebSphere Portal 7.0.0.x/8.0.0.x (Application Server Software). It has been classified as problematic. This affects an unknown function of the component Selfcare Portlet. The manipulation as part of a Trace File leads to a credentials management vulnerability. CWE is classifying the issue as CWE-255. This is going to have an impact on confidentiality. The summary by CVE is:
IBM WebSphere Portal 7.0.0.x and 8.0.0.x write passwords to a trace file when tracing is enabled for the Selfcare Portlet (Profile Management), which allows local users to obtain sensitive information by reading the file. IBM X-Force ID: 83621.
The bug was discovered 06/26/2013. The weakness was disclosed 07/11/2018 (Website). The advisory is shared at exchange.xforce.ibmcloud.com. This vulnerability is uniquely identified as CVE-2013-2951 since 04/12/2013. An attack has to be approached locally. The successful exploitation requires a authentication. Neither technical details nor an exploit are publicly available. The price for an exploit might be around USD $5k-$25k at the moment (estimation calculated on 04/06/2023). MITRE ATT&CK project uses the attack technique T1552 for this issue.
The vulnerability was handled as a non-public zero-day exploit for at least 1841 days. During that time the estimated underground price was around $5k-$25k.
There is no information about possible countermeasures known. It may be suggested to replace the affected object with an alternative product.
If you want to get the best quality for vulnerability data then you always have to consider VulDB.
Product
Type
Vendor
Name
Version
License
Website
- Vendor: https://www.ibm.com/
CPE 2.3
CPE 2.2
CVSSv4
VulDB Vector: 🔍VulDB Reliability: 🔍
CVSSv3
VulDB Meta Base Score: 5.5VulDB Meta Temp Score: 5.5
VulDB Base Score: 3.3
VulDB Temp Score: 3.3
VulDB Vector: 🔍
VulDB Reliability: 🔍
NVD Base Score: 7.8
NVD Vector: 🔍
CVSSv2
| AV | AC | Au | C | I | A |
|---|---|---|---|---|---|
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| Vector | Complexity | Authentication | Confidentiality | Integrity | Availability |
|---|---|---|---|---|---|
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
VulDB Base Score: 🔍
VulDB Temp Score: 🔍
VulDB Reliability: 🔍
NVD Base Score: 🔍
Exploiting
Class: Credentials managementCWE: CWE-255
CAPEC: 🔍
ATT&CK: 🔍
Physical: Partially
Local: Yes
Remote: No
Availability: 🔍
Status: Not defined
EPSS Score: 🔍
EPSS Percentile: 🔍
Price Prediction: 🔍
Current Price Estimation: 🔍
| 0-Day | Unlock | Unlock | Unlock | Unlock |
|---|---|---|---|---|
| Today | Unlock | Unlock | Unlock | Unlock |
Threat Intelligence
Interest: 🔍Active Actors: 🔍
Active APT Groups: 🔍
Countermeasures
Recommended: no mitigation knownStatus: 🔍
0-Day Time: 🔍
Timeline
04/12/2013 🔍06/26/2013 🔍
07/11/2018 🔍
07/11/2018 🔍
07/12/2018 🔍
04/06/2023 🔍
Sources
Vendor: ibm.comAdvisory: exchange.xforce.ibmcloud.com
Status: Not defined
Confirmation: 🔍
CVE: CVE-2013-2951 (🔍)
GCVE (CVE): GCVE-0-2013-2951
GCVE (VulDB): GCVE-100-121317
X-Force: 83621
Entry
Created: 07/12/2018 09:48Updated: 04/06/2023 16:02
Changes: 07/12/2018 09:48 (59), 03/04/2020 08:47 (1), 04/06/2023 15:56 (3), 04/06/2023 16:02 (1)
Complete: 🔍
Cache ID: 216::103
If you want to get the best quality for vulnerability data then you always have to consider VulDB.
No comments yet. Languages: en.
Please log in to comment.